Viral Mediated Gene Therapy for the Management of Metastatic Thyroid Carcinoma
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
4
Page:
235-244
Author(s):
Leslie J. DeGroot and Rusheng Zhang
Dendritic Cell-Based Immunotherapy in Thyroid Malignancies
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
4
Page:
245-251
Author(s):
Matthias Schott, Werner A. Scherbaum and Jochen Seissler
Telomerase as Drug and Drug Target for the Treatment of Thyroid Cancer
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
4
Page:
253-256
Author(s):
M. A. Zeiger and A. K. Meeker
Novel Molecular Targets in Cancer Chemotherapy Waiting for Discovery
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
421-423
Author(s):
Conrad Kunick
Oncogene Suppression by Small Interfering RNAs
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
349-354
Author(s):
Olaf Heidenreich
Therapeutic Potential of Hammerhead Ribozymes in the Treatment of Hyper-Proliferative Diseases
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
369-386
Author(s):
G. Grassi, P. Dawson, G. Guarnieri, R. Kandolf and M. Grassi
Pharmacological Aspects of (-)-Deprenyl
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
2017-2031
Author(s):
K. Magyar, M. Palfi, T. Tabi, H. Kalasz, B. Szende and E. Szoko
Antisense Strategies
Journal:
Current Molecular Medicine
Volume:
4
Page:
465-487
Author(s):
Stanley T. Crooke
Ribozymes in the Age of Molecular Therapeutics
Journal:
Current Molecular Medicine
Volume:
4
Page:
489-506
Author(s):
Sepideh Bagheri and Mohammed Kashani-Sabet
Therapeutic Antibodies
Journal:
Current Molecular Medicine
Volume:
4
Page:
539-547
Author(s):
Bernd Groner, Cord Hartmann and Winfried Wels